Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000762142 | SCV000892404 | uncertain significance | not provided | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855710 | SCV002254589 | uncertain significance | Combined immunodeficiency due to LRBA deficiency | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 261 of the LRBA protein (p.Lys261Arg). This variant is present in population databases (rs375175981, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with LRBA-related conditions. ClinVar contains an entry for this variant (Variation ID: 624048). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LRBA protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV001855710 | SCV004183464 | uncertain significance | Combined immunodeficiency due to LRBA deficiency | 2024-03-05 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000762142 | SCV005410614 | uncertain significance | not provided | 2024-08-28 | criteria provided, single submitter | clinical testing |